Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.
Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group. Arai H, et al. Among authors: yamashita s. J Atheroscler Thromb. 2018 Jun 1;25(6):521-538. doi: 10.5551/jat.44412. Epub 2018 Apr 7. J Atheroscler Thromb. 2018. PMID: 29628483 Free PMC article. Clinical Trial.
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.
Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T; Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Maruyama T, et al. Among authors: yamashita s. J Atheroscler Thromb. 2004;11(3):131-45. doi: 10.5551/jat.11.131. J Atheroscler Thromb. 2004. PMID: 15256764 Free article.
Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan.
Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T; Research Committeon Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Bujo H, et al. Among authors: yamashita s. J Atheroscler Thromb. 2004;11(3):146-51. doi: 10.5551/jat.11.146. J Atheroscler Thromb. 2004. PMID: 15256765 Free article.
Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target.
Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N. Shimano H, et al. Among authors: yamashita s. J Atheroscler Thromb. 2008 Jun;15(3):116-21. doi: 10.5551/jat.e560. J Atheroscler Thromb. 2008. PMID: 18603817 Free article.
Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis.
Adachi H, Fujiwara Y, Kondo T, Nishikawa T, Ogawa R, Matsumura T, Ishii N, Nagai R, Miyata K, Tabata M, Motoshima H, Furukawa N, Tsuruzoe K, Kawashima J, Takeya M, Yamashita S, Koh GY, Nagy A, Suda T, Oike Y, Araki E. Adachi H, et al. Among authors: yamashita s. Biochem Biophys Res Commun. 2009 Feb 20;379(4):806-11. doi: 10.1016/j.bbrc.2008.12.018. Epub 2008 Dec 16. Biochem Biophys Res Commun. 2009. PMID: 19094966
Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
Sandoval JC, Nakagawa-Toyama Y, Masuda D, Tochino Y, Nakaoka H, Kawase R, Yuasa-Kawase M, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Komuro I, Yamashita S. Sandoval JC, et al. Among authors: yamashita s. J Atheroscler Thromb. 2010 Jun 30;17(6):610-8. doi: 10.5551/jat.3988. Epub 2010 Mar 30. J Atheroscler Thromb. 2010. PMID: 20351468 Free article.
4,513 results